349 related articles for article (PubMed ID: 27638884)
1. CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions.
Fiorito E; Sharma Y; Gilfillan S; Wang S; Singh SK; Satheesh SV; Katika MR; Urbanucci A; Thiede B; Mills IG; Hurtado A
Nucleic Acids Res; 2016 Dec; 44(22):10588-10602. PubMed ID: 27638884
[TBL] [Abstract][Full Text] [Related]
2. A co-ordinated interaction between CTCF and ER in breast cancer cells.
Ross-Innes CS; Brown GD; Carroll JS
BMC Genomics; 2011 Dec; 12():593. PubMed ID: 22142239
[TBL] [Abstract][Full Text] [Related]
3. CTCF: the protein, the binding partners, the binding sites and their chromatin loops.
Holwerda SJ; de Laat W
Philos Trans R Soc Lond B Biol Sci; 2013; 368(1620):20120369. PubMed ID: 23650640
[TBL] [Abstract][Full Text] [Related]
4. Variable Extent of Lineage-Specificity and Developmental Stage-Specificity of Cohesin and CCCTC-Binding Factor Binding Within the Immunoglobulin and T Cell Receptor Loci.
Loguercio S; Barajas-Mora EM; Shih HY; Krangel MS; Feeney AJ
Front Immunol; 2018; 9():425. PubMed ID: 29593713
[TBL] [Abstract][Full Text] [Related]
5. CTCF-mediated chromatin loops enclose inducible gene regulatory domains.
Oti M; Falck J; Huynen MA; Zhou H
BMC Genomics; 2016 Mar; 17():252. PubMed ID: 27004515
[TBL] [Abstract][Full Text] [Related]
6. YY1 and CTCF orchestrate a 3D chromatin looping switch during early neural lineage commitment.
Beagan JA; Duong MT; Titus KR; Zhou L; Cao Z; Ma J; Lachanski CV; Gillis DR; Phillips-Cremins JE
Genome Res; 2017 Jul; 27(7):1139-1152. PubMed ID: 28536180
[TBL] [Abstract][Full Text] [Related]
7. The BET Protein BRD2 Cooperates with CTCF to Enforce Transcriptional and Architectural Boundaries.
Hsu SC; Gilgenast TG; Bartman CR; Edwards CR; Stonestrom AJ; Huang P; Emerson DJ; Evans P; Werner MT; Keller CA; Giardine B; Hardison RC; Raj A; Phillips-Cremins JE; Blobel GA
Mol Cell; 2017 Apr; 66(1):102-116.e7. PubMed ID: 28388437
[TBL] [Abstract][Full Text] [Related]
8. BAP18 facilitates CTCF-mediated chromatin accessible to regulate enhancer activity in breast cancer.
Sun G; Wei Y; Zhou B; Wang M; Luan R; Bai Y; Li H; Wang S; Zheng D; Wang C; Wang S; Zeng K; Liu S; Lin L; He M; Zhang Q; Zhao Y
Cell Death Differ; 2023 May; 30(5):1260-1278. PubMed ID: 36828916
[TBL] [Abstract][Full Text] [Related]
9. CCCTC-binding factor confines the distal action of estrogen receptor.
Chan CS; Song JS
Cancer Res; 2008 Nov; 68(21):9041-9. PubMed ID: 18974150
[TBL] [Abstract][Full Text] [Related]
10. Promoter-proximal CTCF binding promotes distal enhancer-dependent gene activation.
Kubo N; Ishii H; Xiong X; Bianco S; Meitinger F; Hu R; Hocker JD; Conte M; Gorkin D; Yu M; Li B; Dixon JR; Hu M; Nicodemi M; Zhao H; Ren B
Nat Struct Mol Biol; 2021 Feb; 28(2):152-161. PubMed ID: 33398174
[TBL] [Abstract][Full Text] [Related]
11. Chromatin Domain Organization of the TCRb Locus and Its Perturbation by Ectopic CTCF Binding.
Rawat P; Jalan M; Sadhu A; Kanaujia A; Srivastava M
Mol Cell Biol; 2017 May; 37(9):. PubMed ID: 28137913
[TBL] [Abstract][Full Text] [Related]
12. A dynamic CTCF chromatin binding landscape promotes DNA hydroxymethylation and transcriptional induction of adipocyte differentiation.
Dubois-Chevalier J; Oger F; Dehondt H; Firmin FF; Gheeraert C; Staels B; Lefebvre P; Eeckhoute J
Nucleic Acids Res; 2014; 42(17):10943-59. PubMed ID: 25183525
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional genome architectural CCCTC-binding factor makes choice in duplicated enhancers at Pcdhα locus.
Wu Y; Jia Z; Ge X; Wu Q
Sci China Life Sci; 2020 Jun; 63(6):835-844. PubMed ID: 32249388
[TBL] [Abstract][Full Text] [Related]
14. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
Eldholm V; Haugen A; Zienolddiny S
Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
[TBL] [Abstract][Full Text] [Related]
15. CTCF shapes chromatin structure and gene expression in health and disease.
Dehingia B; Milewska M; Janowski M; Pękowska A
EMBO Rep; 2022 Sep; 23(9):e55146. PubMed ID: 35993175
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer.
Achinger-Kawecka J; Valdes-Mora F; Luu PL; Giles KA; Caldon CE; Qu W; Nair S; Soto S; Locke WJ; Yeo-Teh NS; Gould CM; Du Q; Smith GC; Ramos IR; Fernandez KF; Hoon DS; Gee JMW; Stirzaker C; Clark SJ
Nat Commun; 2020 Jan; 11(1):320. PubMed ID: 31949157
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association.
Tonsing-Carter E; Hernandez KM; Kim CR; Harkless RV; Oh A; Bowie KR; West-Szymanski DC; Betancourt-Ponce MA; Green BD; Lastra RR; Fleming GF; Chandarlapaty S; Conzen SD
Breast Cancer Res; 2019 Jul; 21(1):82. PubMed ID: 31340854
[TBL] [Abstract][Full Text] [Related]
18. Influence of a CTCF-Dependent Insulator on Multiple Aspects of Enhancer-Mediated Chromatin Organization.
Varma G; Rawat P; Jalan M; Vinayak M; Srivastava M
Mol Cell Biol; 2015 Oct; 35(20):3504-16. PubMed ID: 26240285
[TBL] [Abstract][Full Text] [Related]
19. The Glucocorticoid Receptor Regulates the ANGPTL4 Gene in a CTCF-Mediated Chromatin Context in Human Hepatic Cells.
Nakamoto M; Ishihara K; Watanabe T; Hirosue A; Hino S; Shinohara M; Nakayama H; Nakao M
PLoS One; 2017; 12(1):e0169225. PubMed ID: 28056052
[TBL] [Abstract][Full Text] [Related]
20. Facultative CTCF sites moderate mammary super-enhancer activity and regulate juxtaposed gene in non-mammary cells.
Willi M; Yoo KH; Reinisch F; Kuhns TM; Lee HK; Wang C; Hennighausen L
Nat Commun; 2017 Jul; 8():16069. PubMed ID: 28714474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
